Kaliumchloride - Natriumchloride B. Braun

Potassium chloride and sodium chloride, the active ingredients in Kaliumchloride - Natriumchloride B. Braun, is a electrolyte solution presented as an injection solution for intravenous use. It helps correct low potassium or sodium levels and supports overall electrolyte balance in patients requiring replacement therapy.

GNH USA supplies Kaliumchloride - Natriumchloride B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide, adhering to stringent quality standards and providing reliable global distribution for clinical use.

Kaliumchloride - Natriumchloride is used as an intravenous electrolyte solution to restore and maintain electrolyte concentrations.

- Hypokalemia: restores potassium levels and prevents cardiac complications. - Hyponatremia: supplies sodium ions to correct low serum sodium. - Electrolyte replacement: provides both potassium and sodium for comprehensive electrolyte repletion. - Fluid balance maintenance: assists in managing fluid and electrolyte homeostasis during acute care.

Intravenous administration of Kaliumchloride - Natriumchloride may be associated with the following adverse reactions.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Erythema or swelling: local irritation or redness. - Hyperkalemia: modest rise in serum potassium. - Hypernatremia: modest rise in serum sodium. - Nausea: occasional gastrointestinal upset. - Phlebitis: inflammation of the vein.

Serious or Rare Side Effects: - Cardiac arrhythmia: potentially life‑threatening rhythm disturbances. - Severe hyperkalemia: marked elevation of potassium leading to cardiac arrest. - Anaphylactic reaction: rare severe allergic response. - Severe hypernatremia: rapid increase in sodium causing neurologic symptoms.

When using Kaliumchloride - Natriumchloride, clinicians should observe the following precautions.

- Monitor serum electrolytes: check potassium and sodium levels before and during therapy. - Adjust infusion rate in renal impairment: slower administration to avoid accumulation. - Avoid rapid infusion: limit to recommended maximum rate to prevent cardiac effects. - Use caution in cardiac disease: patients with arrhythmias may be more sensitive. - Contraindicated in existing hyperkalemia: do not administer if potassium is already elevated. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kaliumchloride - Natriumchloride can interact with other medicines; awareness of the following interactions is important.

Major Interactions (Avoid): - ACE inhibitors or ARBs: may increase serum potassium and risk of hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): can cause dangerous potassium accumulation. - Trimethoprim‑containing antibiotics: may elevate potassium levels.

Moderate Interactions (Monitor Closely): - Digoxin: altered potassium levels can affect digoxin toxicity. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may reduce renal potassium excretion. - Other intravenous fluids containing electrolytes: risk of over‑correction if combined.